| | | | | |
| | | | |
| Materials of Construction |
|
| |
| |
| |
| |
| | 1/4 in. hose barb with double O-ring seal |
|
|
| | ≥1100 mbar (16 psig) with 70//30 % IPA/water |
|
| | | ≤9 mL/min @ 965 mbar (14 psig) in 70//30 % IPA/water |
| | ≤12 mL/min @ 965 mbar (14 psig) in 70//30 % IPA/water |
| | ≤24 mL/min @ 965 mbar (14 psig) in 70//30 % IPA/water |
|
| | ≤0.12 mL/min @ 2.6 bar (38 psig) |
| | ≤0.25 mL/min @ 2.6 bar (38 psig) |
| | ≤0.38 mL/min @ 2.6 bar (38 psig) |
| | ≤0.75 mL/min @ 2.6 bar (38 psig) |
|
| Maximum Inlet Pressure, bar (psid) |
| | 5.5 (80) @ 25 °C; 2.8 (40) @ 60 °C; 1.0 (15) @ 80 °C |
|
| Maximum Differential Pressure, bar (psid) |
| | Forward - 5.5 (80) @ 25 °C; 1.0 (15) @ 80 °C; Reverse - 4.1 (60) @ 25 °C, intermittent |
|
| NVR Gravimetric Extractables |
| | ≤15 mg in 70//30 % IPA/water |
| | ≤15 mg in 70//30 % IPA/water |
| | ≤28 mg in 70//30 % IPA/water |
| | ≤45 mg in 70//30 % IPA/water |
|
| Aqueous extraction contains <0.5 EU/mL as determined by the LAL test
|
|
| | Quantitative retention of 107 CFU/cm2 Brevundimonas diminuta ATCC® 19146 per ASTM methodology. |
|
| | 30 autoclave cycles of 30 min @ 135 °C; not in-line steam sterilizable |
|
| | Component materials meet the criteria of the USP <88> Reactivity Test for Class VI Plastics. These products meet the requirements of the USP <88> Safety Test, utilizing a 0.9% sodium chloride extraction. |
|
| Good Manufacturing Practices |
| | These products are manufactured in a facility which adheres to FDA Device Good Manufacturing Practices. |
|
| | Component materials meet the "non-fiber releasing" criteria as defined in 21 CFR 210.3 (b) (6). |
|
| European Pressure Equipment Directive |
| | Millipore Corporation certifies that this product complies with the European Pressure Equipment Directive, 97/23/EC of 29 May 1997. This product has been classified under Article 3 § 3 of the Pressure Vessel Directive. It has been designed and manufactured in accordance with sound engineering practice to ensure safe use. In compliance with Article 3 § 3 of this Pressure Equipment Directive, this product does not bear the CE mark. |
|
| | Rated for aerosol retention of a total challenge of 1081010 plaque forming units of FX174 virus particles at 85 Nm3/h (50 SCFM) per cartridge. |
|
| | Retains Brevundimonas diminuta liquid aerosol for 21 days at a minimum challenge of 107 CFU/cm2. |
|